General MedicationsTOPICALStandard
CALCIPOTRIENE
CALCIPOTRIENE
Standard Dose
0.005%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CALCIPOTRIENE is listed in Drugs@FDA under application 090633 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CALCIPOTRIENE Form and strength OINTMENT;TOPICAL - 0.005% Sponsor GLENMARK PHARMS Submission history Latest submission status date: 2019-05-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview CALCIPOTRIENE is listed in Drugs@FDA under application 090633 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CALCIPOTRIENE Form and strength OINTMENT;TOPICAL - 0.005% Sponsor GLENMARK PHARMS Submission history Latest submission status date: 2019-05-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.